{"id":170466,"date":"2025-11-18T11:50:46","date_gmt":"2025-11-18T10:50:46","guid":{"rendered":"https:\/\/www.financial-news.co.uk\/?p=170466"},"modified":"2025-11-18T11:50:46","modified_gmt":"2025-11-18T10:50:46","slug":"vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces","status":"publish","type":"post","link":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/","title":{"rendered":"VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces"},"content":{"rendered":"<p data-start=\"2014\" data-end=\"2276\">BioNet, a biotechnology firm advancing innovative vaccine solutions, reported today that the European Medicines Agency\u2019s CHMP has delivered a supportive opinion recommending EU marketing approval for VacPertagen, the company\u2019s acellular pertussis vaccine.<\/p>\n<p data-start=\"2278\" data-end=\"2415\">Findings from three clinical studies involving adults, adolescent groups, and pregnant women clearly demonstrated the vaccine\u2019s benefits.<\/p>\n<p><strong>Expert perspectives on pertussis prevention <\/strong><\/p>\n<p>\u201cReceiving a positive CHMP opinion for VacPertagen reflects years of scientific innovation and clinical development with collaborative efforts across continents,\u201d said Prof. Emeritus <strong>Stanley Plotkin<\/strong>, chairman of the BioNet Scientific Advisory Board and an eminent expert in vaccinology.<\/p>\n<p>\u201cA pertussis-only vaccine is particularly valuable for use during pregnancy in countries where pertussis maternal immunisation programs are recommended for pregnant women who are up-to-date with their diphtheria and tetanus immunisations.\u201d<\/p>\n<p><strong>BioNet leadership comments<\/strong><\/p>\n<p>\u201cThis is the first standalone pertussis vaccine to receive a CHMP favourable opinion through the centralised procedure in the European Union,\u201d said <strong>Philippe Guillot-Ch\u00eane<\/strong>, CEO, BioNet Europe.<\/p>\n<p>\u201cThis marks a historic milestone for BioNet and validates our vision to develop an improved pertussis-only vaccine specifically designed to address the re-emergence of pertussis globally.\u201d<\/p>\n<p><strong>About pertussis disease <\/strong><\/p>\n<p>Pertussis is a highly contagious respiratory disease that poses a significant risk to newborns and older adults. The recent resurgence of pertussis cases across Europe underscores the urgent need to strengthen prevention through maternal immunisation and booster vaccination programs.<\/p>\n<p><strong>About VacPertagen<\/strong><\/p>\n<p>VacPertagen is the world\u2019s only available monovalent acellular pertussis vaccine containing two components, including a recombinant Pertussis Toxin (PT<sub>gen<\/sub>). As a non-combined vaccine, VacPertagen aligns with current pertussis vaccination recommendations while avoiding the administration of unnecessary antigens. A pertussis-only vaccine is indeed relevant for use during pregnancy in countries where flexibility in maternal immunisation strategies is needed. In adolescents and adults, VacPertagen has demonstrated long-lasting pertussis antibody persistence.<\/p>\n<p><strong>About BioNet<\/strong><\/p>\n<p>BioNet is a pioneering biotechnology group developing and manufacturing next-generation vaccines, including recombinant and mRNA vaccines. BioNet is operating in 25 countries with a direct presence in Europe and Asia-Pacific. For the past 10 years, BioNet has been producing recombinant pertussis-containing vaccines.<\/p>\n<p>More information: <a href=\"mailto:info@bionet.one\">info@bionet.one<\/a><\/p>\n<p><a href=\"http:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vacpertagen\">www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vacpertagen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BioNet, a biotechnology firm advancing innovative vaccine solutions, reported today that the European Medicines Agency\u2019s CHMP has delivered a supportive opinion recommending EU marketing approval for VacPertagen, the company\u2019s acellular pertussis vaccine. Findings from three clinical studies involving adults, adolescent groups, and pregnant women clearly demonstrated the vaccine\u2019s benefits. Expert perspectives on pertussis prevention \u201cReceiving<\/p>\n","protected":false},"author":50,"featured_media":170468,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[374],"tags":[],"class_list":{"0":"post-170466","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces - Financial News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces - Financial News\" \/>\n<meta property=\"og:description\" content=\"BioNet, a biotechnology firm advancing innovative vaccine solutions, reported today that the European Medicines Agency\u2019s CHMP has delivered a supportive opinion recommending EU marketing approval for VacPertagen, the company\u2019s acellular pertussis vaccine. Findings from three clinical studies involving adults, adolescent groups, and pregnant women clearly demonstrated the vaccine\u2019s benefits. Expert perspectives on pertussis prevention \u201cReceiving\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/\" \/>\n<meta property=\"og:site_name\" content=\"Financial News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/financialnewsUK\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T10:50:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@financialnewsuk\" \/>\n<meta name=\"twitter:site\" content=\"@financialnewsuk\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/\"},\"author\":{\"name\":\"News Team\",\"@id\":\"https:\/\/www.financial-news.co.uk\/#\/schema\/person\/4e1ad09e470253886407a48b6b16add6\"},\"headline\":\"VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces\",\"datePublished\":\"2025-11-18T10:50:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/\"},\"wordCount\":361,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.financial-news.co.uk\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg\",\"articleSection\":[\"Business\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/\",\"url\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/\",\"name\":\"VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces - Financial News\",\"isPartOf\":{\"@id\":\"https:\/\/www.financial-news.co.uk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg\",\"datePublished\":\"2025-11-18T10:50:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#primaryimage\",\"url\":\"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg\",\"contentUrl\":\"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.financial-news.co.uk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.financial-news.co.uk\/#website\",\"url\":\"https:\/\/www.financial-news.co.uk\/\",\"name\":\"Financial News\",\"description\":\"Reliable, up-to-date source for financial news distribution and PR. Find the latest news on insurance, banking, property and mortgages and more.\",\"publisher\":{\"@id\":\"https:\/\/www.financial-news.co.uk\/#organization\"},\"alternateName\":\"financial-news.co.uk\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.financial-news.co.uk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.financial-news.co.uk\/#organization\",\"name\":\"Financial News\",\"alternateName\":\"financial-news.co.uk\",\"url\":\"https:\/\/www.financial-news.co.uk\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.financial-news.co.uk\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2024\/10\/cropped-fav.png\",\"contentUrl\":\"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2024\/10\/cropped-fav.png\",\"width\":512,\"height\":512,\"caption\":\"Financial News\"},\"image\":{\"@id\":\"https:\/\/www.financial-news.co.uk\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/financialnewsUK\",\"https:\/\/x.com\/financialnewsuk\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.financial-news.co.uk\/#\/schema\/person\/4e1ad09e470253886407a48b6b16add6\",\"name\":\"News Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.financial-news.co.uk\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/90ba10d09e1adb08992f0244b393725d569a8b1f2b35a3dc41493b0b5ccf60a1?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/90ba10d09e1adb08992f0244b393725d569a8b1f2b35a3dc41493b0b5ccf60a1?s=96&d=blank&r=g\",\"caption\":\"News Team\"},\"url\":\"https:\/\/www.financial-news.co.uk\/author\/news-team\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces - Financial News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/","og_locale":"en_GB","og_type":"article","og_title":"VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces - Financial News","og_description":"BioNet, a biotechnology firm advancing innovative vaccine solutions, reported today that the European Medicines Agency\u2019s CHMP has delivered a supportive opinion recommending EU marketing approval for VacPertagen, the company\u2019s acellular pertussis vaccine. Findings from three clinical studies involving adults, adolescent groups, and pregnant women clearly demonstrated the vaccine\u2019s benefits. Expert perspectives on pertussis prevention \u201cReceiving","og_url":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/","og_site_name":"Financial News","article_publisher":"https:\/\/www.facebook.com\/financialnewsUK","article_published_time":"2025-11-18T10:50:46+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg","type":"image\/jpeg"}],"author":"News Team","twitter_card":"summary_large_image","twitter_creator":"@financialnewsuk","twitter_site":"@financialnewsuk","twitter_misc":{"Written by":"News Team","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#article","isPartOf":{"@id":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/"},"author":{"name":"News Team","@id":"https:\/\/www.financial-news.co.uk\/#\/schema\/person\/4e1ad09e470253886407a48b6b16add6"},"headline":"VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces","datePublished":"2025-11-18T10:50:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/"},"wordCount":361,"commentCount":0,"publisher":{"@id":"https:\/\/www.financial-news.co.uk\/#organization"},"image":{"@id":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#primaryimage"},"thumbnailUrl":"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg","articleSection":["Business"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/","url":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/","name":"VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces - Financial News","isPartOf":{"@id":"https:\/\/www.financial-news.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#primaryimage"},"image":{"@id":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#primaryimage"},"thumbnailUrl":"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg","datePublished":"2025-11-18T10:50:46+00:00","breadcrumb":{"@id":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#primaryimage","url":"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg","contentUrl":"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.financial-news.co.uk\/vacpertagen-pertussis-vaccine-receives-supportive-chmp-opinion-bionet-announces\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.financial-news.co.uk\/"},{"@type":"ListItem","position":2,"name":"VacPertagen Pertussis Vaccine Receives Supportive CHMP Opinion, BioNet Announces"}]},{"@type":"WebSite","@id":"https:\/\/www.financial-news.co.uk\/#website","url":"https:\/\/www.financial-news.co.uk\/","name":"Financial News","description":"Reliable, up-to-date source for financial news distribution and PR. Find the latest news on insurance, banking, property and mortgages and more.","publisher":{"@id":"https:\/\/www.financial-news.co.uk\/#organization"},"alternateName":"financial-news.co.uk","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.financial-news.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.financial-news.co.uk\/#organization","name":"Financial News","alternateName":"financial-news.co.uk","url":"https:\/\/www.financial-news.co.uk\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.financial-news.co.uk\/#\/schema\/logo\/image\/","url":"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2024\/10\/cropped-fav.png","contentUrl":"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2024\/10\/cropped-fav.png","width":512,"height":512,"caption":"Financial News"},"image":{"@id":"https:\/\/www.financial-news.co.uk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/financialnewsUK","https:\/\/x.com\/financialnewsuk"]},{"@type":"Person","@id":"https:\/\/www.financial-news.co.uk\/#\/schema\/person\/4e1ad09e470253886407a48b6b16add6","name":"News Team","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.financial-news.co.uk\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/90ba10d09e1adb08992f0244b393725d569a8b1f2b35a3dc41493b0b5ccf60a1?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/90ba10d09e1adb08992f0244b393725d569a8b1f2b35a3dc41493b0b5ccf60a1?s=96&d=blank&r=g","caption":"News Team"},"url":"https:\/\/www.financial-news.co.uk\/author\/news-team\/"}]}},"jetpack_featured_media_url":"https:\/\/www.financial-news.co.uk\/wp-content\/uploads\/2025\/11\/BioNet-Receives-Positive-CHMP-Opinion-from-EMA-for-VacPertagen-scaled.jpg","_links":{"self":[{"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/posts\/170466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/users\/50"}],"replies":[{"embeddable":true,"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/comments?post=170466"}],"version-history":[{"count":1,"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/posts\/170466\/revisions"}],"predecessor-version":[{"id":170469,"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/posts\/170466\/revisions\/170469"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/media\/170468"}],"wp:attachment":[{"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/media?parent=170466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/categories?post=170466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.financial-news.co.uk\/wp-json\/wp\/v2\/tags?post=170466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}